We unpacked the controversies and possible market-based solutions generated by the new FDA-approved drug to treat patients with Alzheimer's Disease on today's episode of the 4sight Friday Roundup podcast.
Here the week's biggest news around market-based change.
- David Johnson is CEO of 4sight Health.
- Julie Vaughan Murchinson is Partner of Transformation Capital and former CEO of Health Evolution.
- David Burda is News Editor and Columnist of 4sight Health.
Subscribe on iTunes, Spotify, other services.
Click play to listen to the 6/11/2021 Episode.
